SUMATRIPTAN SUCCINATE
| Brand name | SUMAVEL DOSEPRO |
|---|---|
| Active ingredient | SUMATRIPTAN SUCCINATE |
| Strength | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) |
| Dosage form | INJECTABLE |
| Route | SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | July 2009 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7776007 | November 2026 | product |
| 7901385 | July 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.